Skip Nav Destination
Issues
1 March 1998
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Issue Sections
Review
Advances in Brief
Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
L Liebes; M Potmesil; T Kim; D Pease; M Buckley; D Fry; J Cho; H Adler; K Dar; A Zeleniuch-Jacquotte; H Hochster
Research Articles
Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks.
S G Eckhardt; S D Baker; J R Eckardt; T G Burke; D L Warner; J G Kuhn; G Rodriguez; S Fields; A Thurman; L Smith; M L Rothenberg; L White; P Wissel; R Kunka; S DePee; D Littlefield; H A Burris; D D Von Hoff; E K Rowinsky
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
O Eton; D D Kharkevitch; M A Gianan; M I Ross; K Itoh; M W Pride; C Donawho; A C Buzaid; P F Mansfield; J E Lee; S S Legha; C Plager; N E Papadopoulos; A Y Bedikian; R S Benjamin; C M Balch
Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.
S F Slovin; H I Scher; C R Divgi; V Reuter; G Sgouros; M Moore; K Weingard; R Pettengall; M Imbriaco; A El-Shirbiny; R Finn; J Bronstein; C Brett; D Milenic; A Dnistrian; L Shapiro; J Schlom; S M Larson
Advertisement